Method
Level · gp.fundamentals.debt_to_revenue
Raw value 339.04% · OPTIONAL
· Services-General Medical & Surgical Hospitals, NEC
RESEARCH SNAPSHOTCOMMUNITY HEALTH SYSTEMS INC's latest supported as-filed period reports revenue of $2.8B, 9.8% below the comparable as-filed period. Every value below links to its SEC accession and metric lineage.
No material rule-based research observation currently meets GrossPattern's Insight value threshold. Current state, direction, and filing evidence remain available below.
A multidimensional view of the latest comparable filing—not a composite score or recommendation.
Level · gp.fundamentals.debt_to_revenue
Raw value 339.04% · OPTIONAL
Level · gp.fundamentals.capex_revenue_ratio
Raw value 2.69% · OPTIONAL
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
Raw value 3.12% · OPTIONAL
Yoy · gp.fundamentals.revenue
Raw value -9.83% · CORE
Level · gp.fundamentals.gross_margin
Raw value 85.81% · CORE
Level · gp.fundamentals.operating_margin
Raw value 13.77% · CORE
Level · gp.fundamentals.sbc_revenue_ratio
Raw value 0.07% · OPTIONAL
Business direction, financial quality, capital allocation, and governance evidence remain separate—never collapsed into a recommendation score.
Interpretation boundary Direction describes measurable company fundamentals. Governance reports observable evidence only; it does not grade management character or predict stock returns.
Latest available comparable states within 180 days, normalized with robust median/MAD statistics.
The most important deterministic changes, ranked by magnitude, issuer history, persistence, and accounting profile.
Cash & equivalents changed -67.3% from the comparable as-filed period.
Net income changed -75.2% from the comparable as-filed period.
Operating income changed -24.0% from the comparable as-filed period.
Operating margin moved -2.57 percentage points from the comparable as-filed period.
Each point keeps the date investors could first observe it and its accession.
CYH · as filed with the SEC · reported-date aware
Direct SEC links, filing dates, report periods, and amendment flags.
0001193125-26-365379SEC ↗10-QJul 23, 2026Period Jun 30, 20260001193125-26-314196SEC ↗8-KJul 22, 2026Period Jul 22, 20260001193125-26-312454SEC ↗4Jun 30, 2026Period Jun 30, 20260001193125-26-290763SEC ↗4Jun 1, 2026Period Jun 1, 20260001193125-26-251834SEC ↗8-KJun 1, 2026Period Jun 1, 20260001193125-26-251540SEC ↗8-KMay 13, 2026Period May 13, 20260001193125-26-221742SEC ↗Transaction semantics distinguish purchases, sales, awards, exercises, withholding, and derivatives.
| Filed / transacted | Reporting owner | Semantics | Shares | Price | Notional | Source |
|---|---|---|---|---|---|---|
| Aug 25, 2026Filed Aug 25, 2026 | JENNINGS WILLIAM NORRISDirector | Open Market SaleDirect | 40,000 | $3 | $118,400 | Form 4 ↗ |
| Jun 30, 2026Filed Jun 30, 2026 | Krishnan K RangaDirector | Option ExerciseDirect | 13,930.68 | $0 | $0 | Form 4 ↗ |
| Jun 30, 2026Filed Jun 30, 2026 | Krishnan K RangaDirector | Option ExerciseDirect | 13,930 | $0 | $0 | Form 4 ↗ |
| Jun 1, 2026Filed Jun 1, 2026 | Rice David V.EVP-Clinical Operations & CMO | Grant Or AwardDirect | 30,000 | $0 | $0 | Form 4 ↗ |
| Jun 1, 2026Filed Jun 1, 2026 |
GrossPattern stores immutable raw artifacts, accession-scoped facts, parser and metric versions, dependency edges, quality state, and channel-specific publication rights. A restricted or unknown ancestor blocks the page and API automatically.
SEC source policy ↗Revenue changed -9.8% from the comparable as-filed period.
Stock-based compensation changed -33.3% from the comparable as-filed period.
Method note “Materiality” here is an analytical magnitude band, not a legal conclusion. Full filing-text semantic changes remain unpublished while excerpt rights and review thresholds are unresolved.
Latest supported period in this snapshot: 2026-06-30. Duration facts use direct quarterly or annual SEC contexts; GrossPattern does not manufacture missing Q4 values.
0001193125-26-208926| Rice David V.EVP-Clinical Operations & CMO |
| Grant Or AwardDirect |
| 30,000 |
| $0 |
| $0 |
| Form 4 ↗ |
| Jun 1, 2026Filed Jun 1, 2026 | Rice David V.EVP-Clinical Operations & CMO | Grant Or AwardDirect | 30,000 | $0 | $0 | Form 4 ↗ |
| Apr 22, 2026Filed Apr 22, 2026 | Krishnan K RangaDirector | Option ExerciseDirect | 46,950 | $0 | $0 | Form 4 ↗ |
| Apr 22, 2026Filed Apr 22, 2026 | Krishnan K RangaDirector | Option ExerciseDirect | 46,950 | $0 | $0 | Form 4 ↗ |
| Mar 2, 2026Filed Mar 3, 2026 | SMITH WAYNE TDirector | GiftDirect | 19,400 | $0 | $0 | Form 4 ↗ |
| Mar 1, 2026Filed Mar 3, 2026 | STOCKTON KEVIN AEVP, Operations & Development | Grant Or AwardDirect | 60,000 | $0 | $0 | Form 4 ↗ |
| Mar 1, 2026Filed Mar 3, 2026 | STOCKTON KEVIN AEVP, Operations & Development | Option ExerciseDirect | 50,000 | $0 | $0 | Form 4 ↗ |
| Mar 1, 2026Filed Mar 3, 2026 | STOCKTON KEVIN AEVP, Operations & Development | Tax WithholdingDirect | 35,573 | $3 | $123,083 | Form 4 ↗ |
| Mar 1, 2026Filed Mar 3, 2026 | Pitt Justin DPres,Chief Legal&Admin Officer | Option ExerciseDirect | 30,000 | $0 | $0 | Form 4 ↗ |
| Mar 1, 2026Filed Mar 3, 2026 | STOCKTON KEVIN AEVP, Operations & Development | Grant Or AwardDirect | 30,000 | $0 | $0 | Form 4 ↗ |
| Mar 1, 2026Filed Mar 3, 2026 | Posey Phillip A.SVP & CAO | Grant Or AwardDirect | 25,000 | $0 | $0 | Form 4 ↗ |
| Mar 1, 2026Filed Mar 3, 2026 | Posey Phillip A.SVP & CAO | Tax WithholdingDirect | 1,188 | $3 | $4,110 | Form 4 ↗ |
| Mar 1, 2026Filed Mar 3, 2026 | Posey Phillip A.SVP & CAO | Grant Or AwardDirect | 25,000 | $0 | $0 | Form 4 ↗ |
| Mar 1, 2026Filed Mar 3, 2026 | Posey Phillip A.SVP & CAO | Grant Or AwardDirect | 25,000 | $0 | $0 | Form 4 ↗ |
| Mar 1, 2026Filed Mar 3, 2026 | STOCKTON KEVIN AEVP, Operations & Development | Grant Or AwardDirect | 30,000 | $0 | $0 | Form 4 ↗ |
| Mar 1, 2026Filed Mar 3, 2026 | STOCKTON KEVIN AEVP, Operations & Development | Option ExerciseDirect | 50,000 | $0 | $0 | Form 4 ↗ |